Showing results (441-450 of 455) with videos related to

Sort By:
Pageof 46
European Journal of Human Genetics : EJHG|August 20, 2024
Description and first insights on a large genomic biobank of lung transplantationSimon Brocard, Martin Morin, Nayane Dos Santos Brito Silva, et al.
The British Journal of Dermatology|November 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world settingKarine Billard, Laurent Mortier, Olivier Dereure, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|March 13, 2013
Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research LaboratoriesLesley C Homer, T Scott Alderman, Heather Ann Blair, et al.
JAMA Dermatology|July 16, 2020
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic MelanomaAngélique Brunot, Jean-Jacques Grob, Geraldine Jeudy, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 21, 2026
Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunctionSimon Brocard, Vincent Mauduit, Martin Morin, et al.
Nature Communications|June 4, 2015
Microtubule-associated protein 6 mediates neuronal connectivity through Semaphorin 3E-dependent signalling for axonal growthJean-Christophe Deloulme, Sylvie Gory-Fauré, Franck Mauconduit, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2025
Brain metastases from Merkel cell carcinoma: A nationwide retrospective studyRaphaëlle Caillot, Astrid Blom, Céleste Lebbé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2021
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data<sup>☆</sup>Y Di Filippo, S Dalle, L Mortier, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohortM Kandel, C Allayous, S Dalle, et al.
Cancer|October 23, 2019
Quality-of-life assessment in French patients with metastatic melanoma in real lifeMarguerite Kandel, Stéphane Dalle, Aurélie Bardet, et al.
Pageof 46